Takuro Miyazaki Selected Research

Takuro Miyazaki Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 11/2009
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 11/2012
12	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2012
9	Atherosclerosis 01/2021 - 12/2011
5	Pain (Aches) 10/2021 - 06/2011
5	Hemorrhage 12/2019 - 01/2011
5	Inflammation (Inflammations) 02/2018 - 04/2011
4	Infections 04/2022 - 01/2010
4	Fibrosis (Cirrhosis) 11/2020 - 10/2011
4	Atherosclerotic Plaque (Atheroma) 01/2019 - 12/2011
3	Pathologic Constriction (Stenosis) 04/2022 - 10/2016
3	Disease Progression 05/2021 - 03/2015
2	Malignant Mesothelioma 01/2022 - 04/2018
2	Body Weight (Weight, Body) 01/2022 - 06/2019
2	Carcinogenesis 01/2021 - 01/2018
2	Wounds and Injuries (Trauma) 12/2019 - 01/2019
2	Esophageal Squamous Cell Carcinoma 02/2018 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 08/2016
2	Pathologic Neovascularization 10/2016 - 03/2015
2	Pulmonary Emphysema 06/2015 - 04/2015
2	Emphysema 06/2015 - 05/2013
2	Reperfusion Injury 04/2015 - 09/2014
2	Abdominal Aortic Aneurysm 11/2014 - 05/2014
2	Cystic Fibrosis (Mucoviscidosis) 10/2011 - 01/2010
1	Bronchomalacia 04/2022
1	Lung Diseases (Lung Disease) 04/2022
1	Fistula 04/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Obesity 01/2022
1	Empyema 01/2022
1	Postoperative Pain 10/2021
1	Neuralgia (Stump Neuralgia) 10/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2021
1	Hypercholesterolemia 01/2021
1	Chronic Pancreatitis 11/2020
1	Dyslipidemias (Dyslipidemia) 01/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
8	CalpainIBA 01/2022 - 12/2011
6	AlbuminsIBA 10/2022 - 04/2015
5	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 11/2010
4	C-Reactive ProteinIBA 10/2022 - 04/2015
4	Messenger RNA (mRNA)IBA 01/2022 - 11/2010
4	CytokinesIBA 05/2021 - 03/2015
4	CholesterolIBA 01/2021 - 01/2016
4	ErbB Receptors (EGF Receptor)IBA 01/2016 - 08/2012
3	Therapeutic UsesIBA 08/2021 - 04/2011
3	Biomarkers (Surrogate Marker)IBA 05/2019 - 01/2017
3	Carcinoembryonic AntigenIBA 12/2017 - 04/2015
2	Lipoproteins (Lipoprotein)IBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2021
2	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 06/2019
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor CIBA 01/2021 - 03/2015
2	Hemostatics (Antihemorrhagics)IBA 12/2019 - 08/2016
2	Biological ProductsIBA 07/2019 - 11/2010
2	SteroidsIBA 07/2019 - 01/2012
2	calpastatinIBA 01/2019 - 03/2015
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019 - 04/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 01/2012
2	oxidized low density lipoproteinIBA 01/2017 - 01/2016
2	LipidsIBA 01/2017 - 01/2016
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2016 - 03/2014
2	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 03/2015 - 09/2014
2	Angiotensin IIIBA 11/2014 - 05/2014
2	Apolipoproteins E (ApoE)IBA 11/2014 - 05/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014 - 05/2014
2	EnzymesIBA 09/2014 - 11/2010
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Radiation-Sensitizing AgentsIBA 01/2022
1	AsbestosIBA 01/2022
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2021
1	mirogabalinIBA 10/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 05/2021
1	Delayed-Action PreparationsIBA 05/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2021
1	PlatinumIBA 03/2021
1	CeruletideIBA 11/2020
1	Extracellular Matrix ProteinsIBA 11/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020

Therapy/Procedure

8	Lung Transplantation 04/2022 - 01/2010
8	Thoracotomy 10/2021 - 06/2011
6	Therapeutics 10/2021 - 04/2011
5	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2014
4	Segmental Mastectomy (Lumpectomy) 11/2021 - 05/2013
3	Chemoradiotherapy 04/2022 - 03/2017
3	Ligation 12/2019 - 01/2011
3	Operative Surgical Procedures 12/2016 - 06/2011
2	Chest Tubes (Chest Tube) 01/2022 - 01/2014
2	Thymectomy 05/2021 - 10/2012
2	Adjuvant Chemotherapy 03/2021 - 11/2012
2	Pneumonectomy (Lung Volume Reduction) 04/2018 - 06/2012
2	Stents 08/2017 - 10/2016
2	Lasers (Laser) 03/2014 - 02/2012
1	Radiotherapy 01/2022
1	Patient Readmission 01/2022